Novel nicotinamide analog as inhibitor of nicotinamide N-methyltransferase

Compound 12 Human/mouse NNMT enzymatic inhibition (IC50): 0.58/4.5 µM. Inhibition of MNA in U2OS/3T3L1 cell based assay: 0.3/2.1 µM. Human/mouse metabolic stability (% remaining after 30 m): 85/69. In vivo target engagement (MNA reduction, 2 h): ∼80%.

Gespeichert in:
Autor*in:

Ruf, Sven [verfasserIn]

Hallur, Mahanandeesha Siddappa

Anchan, Nisha K.

Swamy, Indu N.

Murugesan, Karthikai Raj

Sarkar, Sayantani

Narasimhulu, Lokesh Kananti

Putta, V.P. Rama Kishore

Shaik, Shama

Chandrasekar, Devaraj Venkatapura

Mane, Vishal Subhash

Kadnur, Sanjay Venkatachalapathi

Suresh, Juluri

Bhamidipati, Ravi Kanth

Singh, Manvi

Burri, Raghunadha Reddy

Kristam, Rajendra

Schreuder, Herman

Czech, Joerg

Rudolph, Christine

Marker, Alexander

Langer, Thomas

Mullangi, Ramesh

Yura, Takeshi

Gosu, Ramachandraiah

Kannt, Aimo

Dhakshinamoorthy, Saravanakumar

Rajagopal, Sridharan

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2018

Schlagwörter:

Obesity

Nicotinamide N-methyltransferase (NNMT)

Methyl-nicotinamide (MNA)

Ncotinamide

Diabetes

Umfang:

4

Übergeordnetes Werk:

Enthalten in: Feeding European sea bass ( - Torrecillas, S. ELSEVIER, 2018, a Tetrahedron publication for rapid dissemination of preliminary communications on all aspects of bioorganic chemistry, medicinal chemistry, bioinorganic chemistry and related disciplines, Amsterdam [u.a.]

Übergeordnetes Werk:

volume:28 ; year:2018 ; number:5 ; day:1 ; month:03 ; pages:922-925 ; extent:4

Links:

Volltext

DOI / URN:

10.1016/j.bmcl.2018.01.058

Katalog-ID:

ELV042102197

Nicht das Richtige dabei?

Schreiben Sie uns!